Afatinib ≥95%
Supplier: ADIPOGEN CORP MS
Synonyms:
(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, BIBW2992, Tovok
Afatinib is an irreversible kinase inhibitor and binds to the kinase domains of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4) to inhibit tyrosine kinase autophosphorylation. This results in a downregulation of ErbB signaling and subsequent inhibition of proliferation of cell lines expressing wild-type EGFR, selected EGFR exon 19 deletion mutations, or exon 21 L858R mutations. It also inhibited in vitro proliferation of cell lines overexpressing HER2. Overall, tumor growth was inhibited by Afatinib very effectively with low nanomolar IC(50) values ranging from approximately 6nM to below 500nM.
Formula:
C₂₄H₂₅ClFN₅O₃ MW: 485.94 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD12407405 CAS Number: 850140-72-6 |
Specification Test Results
Purity | >95% |
Appearance/Color | Solid. |
Solubility | Soluble in DMSO or ethanol. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...